Skip to main content

Neurology

One particularly important area where we are placing our Partnering efforts is in Neurology. We believe the field of Neurology is on the cusp of important breakthroughs in both early diagnosis and treatment. Our relentless pursuit of scientific innovation is taking us into areas of enormous unmet medical need and progress in treating diseases of the brain and nervous system.

Our collaborative efforts have resulted in one of the strongest and most diverse pipelines in the industry, spanning the spectrum of nervous system disorders.

Partnering opportunities we are looking for:

  • Neurodegenerative diseases (e.g. Alzheimer's disease, Parkinson's disease, Huntington disease)

  • Neuroinflammation (e.g. Multiple sclerosis)

  • Neuromuscular diseases (e.g. ALS, Duchenne Muscular Dystrophy)

  • Transformational therapies in other CNS indications

Example partnerships

  • Atalanta Therapeutics

    Collaboration entails the development of RNAi therapeutics for multiple CNS targets for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease.

  • Ionis Pharmaceuticals

    Early stage programs for RNA-targeting investigational medicines for the treatment of Alzheimer's disease (AD) and Huntington's disease (HD)

  • Sangamo Therapeutics

    Exclusive license to Sangamo’s proprietary zinc finger repressors directed to the tau gene, which is critically involved in AD and other tauopathies, as well as an undisclosed second neurology target.

Explore collaboration opportunities

Connect with our partnering experts to start the conversation.

More Pharma partnering areas

View all areas
Decorative illustration

Digital and data

Innovation

We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.

Decorative illustration

Immunology

Innovation

Leading the way to advance science in inflammatory and autoimmune diseases.

Decorative illustration

Infectious Diseases

Innovation

We are advancing innovation to combat infectious diseases like HBV, influenza and MDR.

Decorative image

Oncology and Haematology

Innovation

We focus on first- and best-in-class therapeutics in molecular targeted therapies and cancer immunotherapy.

Decorative illustration

Ophthalmology

Innovation

We are focusing on saving people’s eyesight from the leading causes of vision loss through pioneering therapies and cutting- edge research.

Decorative illustration

Research Technologies

Innovation

We focus on therapeutic modalities and enabling technologies.

Decorative illustration

Cardiovascular, Renal & Metabolic Disease

Innovation

Roche is committed to making a contribution to areas of huge unmet need and societal burden through transformative science like in cardiovascular and metabolic diseases

Discover more

  • Neurology

    Pharma | Diagnostics

    We're pushing boundaries of scientific understanding to achieve clinical advancements and solve some of the greatest challenges in neurology today.

  • Ophthalmology

    Innovation

    We are focusing on saving people’s eyesight from the leading causes of vision loss through pioneering therapies and cutting- edge research.

  • Rare disease

    Pharma | Diagnostics

    Working together to build a better world for people with rare diseases.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments